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Aim: The investigation of the irradiation time calculation accuracy of the GGPB algorithm
used for IORT.
Background: Conventionally, breast conserving therapy consists of breast conserving surgery
followed by postoperative whole breast irradiation and boost. The use of intraoperative
radiotherapy (IORT) enables the boost to be delivered already during the surgery. In this
case, the treatment dose for IORT can be calculated by use of General Gaussian Pencil Beam
(GGPB) algorithm, which is implemented in TPS Eclipse.
Materials and methods: PDDs and OFs for electron beams from Mobetron and all available
applicators were measured in order to conﬁgure the GGPB algorithm. Afterwards, the irra-
diation times for the prescribed dose of 3Gy were calculated by means of it. The results of
calculations were veriﬁed in the water phantom using the Marcus ionization chamber.
Results: The results differed between energies. For 6MeV the irradiation times calculated by
the GGPB algorithm were correct, for the energy of 9MeV they were too small and for the
energy of 4MeV they were too large for applicators with smaller diameters, while acceptable
for the remaining ones.Conclusion: The GGPB algorithm can be used in intraoperative radiotherapy for energy and
applicator sets for which no signiﬁcant difference between the measured and the prescribed
dose was obtained. For the rest of energy-applicator sets the conﬁguration should be veriﬁed
and possibly repeated.
land
fractions during 5–6 weeks. WBI is often followed by a boost© 2010 Greater Po
1. Background
Currently, 60–75% of all breast cancer cases are treated with
breast conserving therapy (BCT).1 The rationale for this ther-
apy is that regardless of the tumor the majority (up to 90%2)
of the microscopic foci are located only in the vicinity of
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the initial lesions in the thoracic gland.2–7 In practice, it is a
combination of breast conserving surgery and whole breast
irradiation (WBI). The prescribed dose is 50–55Gy, given into the tumor bed, which reduces recurrence risk by 40%.8
In the paper by Sas-Korczynska et al., different techniques
of postoperative irradiation within breast conserving therapy
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved
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ere described and compared.9 When intraoperative radio-
herapy (IORT) is used, the external boost is replaced by
ntraoperative boost. That kind of treatment minimizes the
eographical error and reduces dose in adjacent tissues, such
s the myocardium and the lung.
The modern IORT was initiated in 1965 by M. Abe at Kyoto
niversity, Japan.10,11 The breakthrough in this method was
he development of dedicated mobile linear accelerators such
s Mobetron. Mobetrons have been produced since 1990s by
ntraOp Medical, Inc.17 Due to the development of that kind
f medical machines, it is possible to apply the whole dose of
adiation during the surgery and in the operating room.
The irradiation time in IORT is usually determined man-
ally on the basis of tabulated data which describe dose
istribution according to the energy, ﬁeld size and depth. It is a
uty of a medical physicist to ﬁnd such beam parameters that
he dose distribution ﬁts best with the dose prescribed by a
adiation oncologist. It is crucial to avoid any failure. Addition-
lly, there is usually more than one possibility of choosing the
eam parameters to provide an acceptable solution. Likewise,
ime needed for this procedure is a relevant factor. Therefore,
he automation of irradiation time calculation is essential.
esults calculated automatically are more reliable as well as
asier and faster to obtain.
One of the possibilities is to use the Generalized Gaus-
ian Pencil Beam (GGPB) algorithm implemented in Treatment
lanning System Eclipse by Varian Medical Systems Inc. It cal-
ulates the three-dimensional dose distribution of electrons
n the irradiated medium and the exposure time in which the
edium will receive the prescribed dose.
. Aim
he aim of this paper was to verify in the water phantom the
ccuracy of the irradiation time calculation done by the Gener-
lized Gaussian Pencil Beam algorithm used in intraoperative
adiotherapy for electrons with energies of 4MeV, 6MeV and
MeV generated by a dedicated Mobetron, and ﬁeld sizes with
iameters from 3cm to 10 cm.
. Materials and methods
.1. Generalized Gaussian Pencil Beam algorithm
he Generalized Gaussian Pencil Beam algorithm, imple-
ented in Treatment Planning System Eclipse by Varian
edical Systems Inc. calculates the three-dimensional dose
istribution of electrons in the irradiated medium and the
xposure time in which the medium will receive the pre-
cribed dose.13
Treatment planning systems calculate the irradiation time
or given parameters of the beam and the radiation ﬁeld
o achieve the desired dose in tissue. The TPS Eclipse pro-
ides a package of several algorithms which calculate the
ose distribution and irradiation time. One of them is the
GPB algorithm which was designed for electron beams. Its
hree-dimensional dose distribution calculation is based on
he Fermi-Eyges electron multiple scattering theory and is the
um of three Gaussian functions. The algorithm calculates thetherapy 1 5 ( 2 0 1 0 ) 132–137 133
dose for irregular ﬁelds with arbitrary orientations and colli-
mator rotation angles. It takes into account inhomogeneity of
the medium, the radiation scattered in the air and the contri-
bution from bremsstrahlung. The accuracy of the calculations
in a heterogeneous medium is ±5% or ±5mm.13
The GGPB algorithm conﬁguration for IORT requires mea-
suring and introducing to the system the following data for
each set of used energy and applicator:
- applicator-speciﬁc depth dose curves (PDD),
- output factors (OFs) which are doses measured at the depth
of the maximum dose depth normalized to the result for the
10 cm applicator,
- electron mean energy derived from PDD,
- normalization factors which ensure that for the calculated
dose distribution the dose at the depth of maximum dose is
100%.13
3.2. Dedicated Mobetron
Electrons were generated by a Mobetron dedicated to intra-
operative radiotherapy, made by IntraOp Medical, Inc. This
device accelerates electrons to nominal energies of 4MeV,
6MeV, 9MeV and 12MeV and emits them with low or high
dose rate, 250MU/min or 1000MU/min, respectively. Electrons
are collimated in an applicator which is placed between the
accelerator’s treatment head and a patient, 4 cm below the
treatment head. There are 15 applicators available with diam-
eters ranging from 3cm to 10 cm and with the increment of
0.5.14 Applicators have a triple function. They collimate the
radiation, determine the radiation ﬁeld and keep healthy tis-
sues and skin out of the radiation ﬁeld.15
A Mobetron consists of three parts: treatment module,
modulator and operators control console. The control con-
sole is used for remote control of the beam during IORT.
Programming the console means choosing all parameters of
the electron beam: nominal energy, irradiation time and dose
rate. In addition, before accepting all parameters and conﬁrm-
ing the beam on setup, it is possible to watch the patient on
the screen at the console, as the beam eye view color video
from the integrated camera is placed in the treatment head.
The accelerator can be also operated from the modulator. This
option, however, applies only to dosimetry, calibration and
measurements made to verify and repair the equipment. It
should be pointed out that while operating the radiation from
the modulator some parts of the beam automatic corrections
are disabled.
3.3. Veriﬁcation of the GGPB
According to the International Atomic Energy Agency TRS 398
report, the dose in water for high energy electron beam with
quality Q is obtained by applying the formula (1)
Dw,Q = MQND,W,Q0kQ,Q0 (1)where MQ is the reading of a dosimeter corrected for the
inﬂuence quantities such as temperature and pressure, elec-
trometer calibration, polarity effect and ion recombination.
ND,w,Q0 is a calibration factor in terms of absorbed dose to
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should be pointed out that the lack of stable radiation per-
formance of the accelerator was noted during measurement.
This resulted not only in observable variations in beam power,
sometimes so large that it was not possible to continue the134 reports of practical oncology an
water for a dosimeter at a reference beam quality Q0, kQ,Q0 is a
correction factor for the difference between the response of an
ionization chamber in the reference beam quality Q0 used for
calibrating the chamber and in the actual user beam quality
Q.16
All data were collected for energies of 4MeV, 6MeV and
9MeV and 15 applicators with diameters from 3cm to 10 cm.
The measurements order was always the same – from the
applicator with the broadest diameter to the applicator with
the narrowest diameter.
For each energy-applicator combination three ionization
current curves were recorded. On the basis of the analysis
made by use of the MEPHYSTO MC2 software by PTW Freiburg
one curve was selected then converted to the PDD and ﬁnally
converted to the ASCI format which is readable by the GGPB
algorithm. The curve selectionwas necessary because of noisy
measurements and some unclear points with lower or higher
(even up to 5%) point dose values. There was no difference
between proper curves, so any of them could be selected
at random. For each PDD, the software calculated the mean
energy and the depth of maximum dose. At this depth in
the beam axis, the dose for output factors was measured. In
this way all data needed for the algorithm conﬁguration were
collected and the algorithm could have been conﬁgured. After-
wards, irradiation times for a water phantom were calculated
by means of this algorithm. The prescribed dose was 3Gy at
the depth of 1 cm for energies of 4MeV and 6MeV and 3cm for
energy of 9MeV. The result of each calculationwas the amount
of monitor units [MU] which after correction for actual beam
efﬁciency was programmed on the operator control console.
The current beam efﬁciency was established directly before
each energy veriﬁcation measurements. The dose for the cal-
culated irradiation time was measured three times. Finally,
the arithmetic mean was compared with the prescribed dose
of 3Gy and the percentage difference was calculated.
3.4. Measuring setup
All of the measurements were performed in the water phan-
tomMP1 andMP3 PTWFreiburg. The ionization current curves
were recorded by use of the MEPHYSTO MC2 software which
allows registration, presentation and data processing. The
dual channel electrometer TANDEM by stem thimble ion-
ization chamber as a reference chamber. The movement of
Markus chamberwas programmed so that, during the acquisi-
tion, itwas alwaysmoving in thedirectionof thewater surface.
For the output factors and veriﬁcation measurements, the
same Markus chamber was used and the UNIDOS dosimeter
by PTW Freiburg.
4. Results
PDDs and OFs required for the algorithm conﬁguration were
introduced to the GGPB algorithm. The obtained PDDs for
the 4MeV, 6MeV and 9MeV electron beams and the 10 cm
applicator are depicted in Fig. 1. Fig. 2 shows the output fac-
tors for all applicators and energy sets relative to the 10 cm
applicator. After completing the algorithm conﬁguration the
irradiation times for all sets of energies and applicators wereFig. 1 – Percentage depth of dose curves for 4MeV, 6MeV
and 9MeV electron beams and 10 cm diameter applicator.
calculated. The results of these calculations are included in
Table 1
The results of the calculation veriﬁcation of the algorithm
for beam energies of 4MeV, 6MeV and 9MeV are shown in
Tables 2–4 respectively. Each of them contains the results of
three dose measurements, their mean and percentage dif-
ference between the mean value and the prescribed dose of
3Gy.
5. Discussion
The veriﬁcation of the calculation accuracy of the GGPB algo-
rithm gave different results for different electron energies. ItFig. 2 – Output factors measured at the depth of maximum
dose for 4MeV, 6MeV and 9MeV electron beams and
applicators from 3cm to 10 cm diameter.
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Table 1 – Irradiation times [MU] for a water phantom
calculated by the GGPB algorithm for 4MeV, 6MeV and
9MeV electron beams and applicators from 3cm to
10 cm diameter. The prescribed dose was 3Gy at the
depth of 1 cm for energies of 4MeV and 6MeV and 3cm
for energies of 9MeV.
Applicator diameter [cm] Energy [MeV]
4 6 9
3.0 584 352 583
3.5 488 319 456
4.0 441 300 392
4.5 403 292 358
5.0 376 286 347
5.5 371 282 330
6.0 352 283 334
6.5 363 297 352
7.0 360 297 357
7.5 357 297 359
8.0 350 299 358
8.5 349 298 377
9.0 352 301 372
9.5 347 292 369
10.0 353 305 381
Table 2 – Three veriﬁcation measurements [Gy] for the 4MeV el
difference between the mean value and the prescribed dose of
Applicator diameter [cm] d1 d2
3.0 3.323 3.332
3.5 3.257 3.265
4.0 3.283 3.287
4.5 3.255 3.256
5.0 3.205 3.227
5.5 3.283 3.286
6.0 3.192 3.206
6.5 3.109 3.119
7.0 3.154 3.160
7.5 3.132 3.135
8.0 3.093 3.089
8.5 3.098 3.098
9.0 3.100 3.102
9.5 3.081 3.084
10.0 3.064 3.058
Table 3 – Tree veriﬁcation measurements [Gy] for the 6MeV ele
difference between the mean value and the prescribed dose of
Applicator diameter [cm] d1 d2
3.0 2.968 2.964
3.5 2.993 2.997
4.0 3.001 2.998
4.5 3.023 3.021
5.0 3.020 3.031
5.5 3.038 3.038
6.0 3.136 3.144
6.5 3.038 3.047
7.0 3.063 3.047
7.5 3.065 3.068
8.0 3.073 3.078
8.5 3.056 3.062
9.0 3.059 3.068
9.5 3.038 3.039
10.0 3.068 3.063therapy 1 5 ( 2 0 1 0 ) 132–137 135
measurements, but also signiﬁcant differences between dose
values, which were measured one after another. The largest
differences were observed for the electron energy of 9MeV,
amountingup to 8% (Table 4). The operationdisturbanceswere
clearly visible also during the registration of ionization current
curves. Isolatedpeaks, steps andchanges in the level of curves’
segments were recorded. In addition, there were a few failures
in the system operation manifested by a sudden interruption
of radiation. Thesewere related to such interlocks as an invalid
proﬁle beam, too high temperature in the therapeutic module
or disrupted vacuum in the accelerating section or the mag-
netron. In the clinical situation radiation is turned on several
times for 1–2min, and then the accelerator remains ready for
use for about 2h until the patient is irradiated, which lasts not
more than 2min. Themeasurements performed for this paper,
on the other hand, lasted usually several hours, so that they
must have overloaded the efﬁciency designed for a clinical use
of the accelerator. It may be concluded that the Mobetron was
overloaded and therefore did not work steadily enough. Dur-
ing IORT, such disruptions do not occur. The radiation is stable
and no signiﬁcant problems arise in the course of treatment.
ectron beam, their mean value and the percentage
3Gy.
d3 Mean Difference [%]
3.339 3.331 11.04
3.263 3.262 8.72
3.303 3.291 9.70
3.260 3.257 8.57
3.223 3.218 7.28
3.293 3.287 9.58
3.191 3.196 6.54
3.151 3.126 4.21
3.156 3.157 5.22
3.131 3.133 4.42
3.091 3.091 3.03
3.103 3.100 3.32
3.100 3.101 3.36
3.085 3.083 2.78
3.062 3.061 2.04
ctron beam, their mean value and the percentage
3Gy.
d3 Mean Difference [%]
2.966 2.966 −1.13
2.986 2.992 −0.27
3.006 3.002 0.06
3.032 3.025 0.84
3.032 3.028 0.92
3.040 3.039 1.29
3.141 3.140 4.68
3.051 3.045 1.51
3.051 3.054 1.79
3.066 3.066 2.21
3.077 3.076 2.53
3.055 3.058 1.92
3.065 3.064 2.13
3.034 3.037 1.23
3.063 3.065 2.16
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Table 4 – Three veriﬁcation measurements [Gy] for the 9MeV electron beam, their mean value and the percentage
difference between the mean value and the prescribed dose of 3Gy.
Applicator diameter [cm] d1 d2 d3 Mean Difference [%]
3.0 3.220 3.194 3.179 3.198 6.59
3.5 2.954 2.929 3.172 3.018 0.61
4.0 2.800 2.771 3.00 2.857 −4.77
4.5 2.710 2.708 2.744 2.721 −9.31
5.0 2.897 2.724 2.700 2.774 −7.54
5.5 2.634 2.601 2.609 2.615 −12.84
6.0 2.808 2.783 2.637 2.743 −8.58
6.5 2.816 2.642 2.665 2.708 −9.74
7.0 2.704 2.668 2.777 2.716 −9.46
7.5 2.716 2.696 2.696 2.703 −9.91
8.0 2.686 2.686 2.782 2.718 −9.40
8.5 2.825 2.815
9.0 2.753 2.749
9.5 2.702 2.712
10.0 2.883 2.784
Itwas assumed that the agreement betweenprescribedand
measured dose is obtained when the percentage difference
between them does not exceed 5%. This level of agreement
was chosen due to calculation algorithm accuracy. The accu-
racy of measurements which were done using PTW Freiburg
systems such as: water phantoms MP1 and MP3 with auto-
matically controlled chamber position, Markus chamber and
Unidos dosimeter with Secondary Standard calibration certiﬁ-
cate was not taken into account.
For the 4MeV beam energy the results of veriﬁcation were
acceptable for measurements which were performed at ﬁrst
(Table 2). Each change of the applicator requires a very small
loss in water. In other words, in the course of measurements
the water level constantly drops. For lower electron energies,
such as 4MeV, the dose distribution in water depends partic-
ularly strongly on the depth, and therefore it can be expected
that even a small change in a water level will signiﬁcantly
affect the meter reading. After the measurements for the
4MeV beam energy, the water level was veriﬁed and it was
found out that it indeed dropped by 0.6mm. The changes in
the level of water could have been taken into account and
corrected. However, it would also imply the need of correct-
ing the distance between applicator and the water surface.
At this point it was important that measurement uncertain-
ties due to the continuous matching of the measuring system
were not greater than those resulting from the loss of water.
Most probably one should rather try to change the applicator
in such a way as to minimize the reduction of water vol-
ume.
After themeasurements also the beamefﬁciencywas again
checked. It turned out that it changed, too, increasing by 1.5%.
It should be noted that veriﬁcation of the calculations for the
energy of 4MeV was performed as the ﬁrst. It was ﬁgured
out that performance changed because the beam efﬁciency
did not reach a constant value before the beginning of the
measurements. Compliance with the higher beam efﬁciency
would result in shorter irradiation time and hence in a lower
dose. Thus, it is possible that the inclusion of changes of the
beam efﬁciency and water level would lead to the satisfactory
outcome. In the case of the unexpectedly large percentage
difference for the 5.5 cm applicator, it was checked that the
value of the mean energy for it was lower than for the adja-2.817 2.819 −6.03
2.756 2.753 −8.24
2.728 2.714 −9.53
2.758 2.808 −6.39
cent applicators. Therefore, it would be advisable to check its
PDD.
For the 6MeV beam energy, the irradiation time was calcu-
lated correctly (Table 3). During the measurements, the water
level dropped by 0.3mm and beam efﬁciency decreased by
0.3%. Nevertheless, it seemed to have no signiﬁcant inﬂuence
on the results.
For the 9MeV beam energy, the irradiation time calculated
by the GGPB algorithm was too short for most applicators
(Table 4). It was veriﬁed that the efﬁciency of the beam had
not changed during the measurements. Due to the fact that
serious problems with Mobetron’s performance arose during
themeasurements of PDD for this energy, itwould be advisable
to re-measure these curves.
The relatively large discrepancy between the prescribed
and the measured doses is likely to be the result of algo-
rithm accuracy and some minor problems with instability of
the accelerator’s performance. While the elimination of the
former, although cumbersome and time-consuming, is in a
fairly high degree possible, the radiation stability can behardly
moderated. It has to be remembered that all the measure-
ments, calculations and veriﬁcations were done in a cubic
water phantom. For patients it is a little bit different situa-
tion – there are some air gaps and the surface is not so ﬂat as
in a phantom. So, basically, there will always be a difference
between calculation and dose absorption by irradiated tissues.
6. Conclusions
The results obtained allow to consider the GGPB algorithm
as a tool which can be used for intraoperative radiotherapy
and not only for conventional radiotherapy. In order to apply
it to all energy and applicator sets, the conﬁguration and the
veriﬁcation measurements should be repeated for those sets
for which a signiﬁcant difference between the measured and
the prescribed dose was obtained. However, considering that
the calculations are made in real-time in a surgeon operating
room, when the patient is already lying on the table and wait-
ing for irradiation, it is most important that no mistakes occur
when very quick changes of the energy or applicator are made
for calculating the best dose distribution. In the next step of
radio
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he study it is now possible to adjust the algorithm not only
or proper beam axis dose and time calculation, but also for
ose distribution at the ﬁeld edges.
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